NCT06093971View on ClinicalTrials.gov

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

NACompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

October 22, 2024

Study Completion Date

October 22, 2024

Conditions

Prostate Tumor

Interventions

DRUG

remimazolam

Remimazolam is administered for anesthesia induction.

DRUG

Propofol

Propofol is administered for anesthesia induction.

Trial Locations (1)

Unknown

Yonsei University College of Medicine, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT06093971 - Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy | Biotech Hunter | Biotech Hunter